Sakar Healthcare Limited

Sakar Healthcare Limited (SAKAR) is a micro-cap Healthcare company valued at ₹2,140 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sakar Healthcare Limited last traded at ₹961.7, down 2.81% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarterly results, showing a sharp rise in both revenue and net profit compared to the prior-year quarter. Promoter holding decreased by 0.34 percentage points to 52.52%, while foreign institutional holding fell by 0.81 percentage points to 12.13%, and domestic institutional holding rose by 0.05 percentage points to 11.37%.

Financial performance

The company's business is improving, with annual revenue rising 41.4% and annual net profit growing 69.3%. The latest quarter saw revenue increase 37.7% compared to the same quarter a year earlier, while net profit surged 105.6%, driven by stronger margins that widened 2.0 percentage points to 12.1%.

Valuation multiples

The stock trades at 70.2 times earnings, a premium to the Healthcare median of 32.0, 7.37 times book value.

Things to watch

The company has not paid any dividends despite reporting repeated profits. The stock is 12.6% below its 52-week high, and promoter holding has declined in the latest quarter. The company's return on equity is 9.4%, which is relatively low compared to its return on capital employed of 12.5%.

Where it stands

Sakar Healthcare Limited has shown strong growth in both revenue and net profit over the past year and quarter, with margins improving. The company's stock is currently 12.6% below its 52-week high, and promoter holding has decreased slightly. The company's return on equity is 9.4%, while its return on capital employed is 12.5%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.